Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients
Receiving an opioid prescription during childhood increases the risk of hazardous prescription opioid (PO) use during emerging adulthood. Instruction on how to safely use POs plays an essential role in pediatric patients’ capacity to utilize as well as to discontinue POs appropriately. This study ai...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Children |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9067/9/5/707 |
| _version_ | 1797500782867644416 |
|---|---|
| author | Denise D. Tran Patrick C. M. Brown Corrin Murphy Diana Ho Karen A. Hudson Anna C. Wilson Sarah W. Feldstein Ewing |
| author_facet | Denise D. Tran Patrick C. M. Brown Corrin Murphy Diana Ho Karen A. Hudson Anna C. Wilson Sarah W. Feldstein Ewing |
| author_sort | Denise D. Tran |
| collection | DOAJ |
| description | Receiving an opioid prescription during childhood increases the risk of hazardous prescription opioid (PO) use during emerging adulthood. Instruction on how to safely use POs plays an essential role in pediatric patients’ capacity to utilize as well as to discontinue POs appropriately. This study aimed to evaluate pediatric PO label instructions provided to a large sample of pediatric outpatients. Data were extracted from the electronic healthcare records system identifying pediatric patients who received a PO between 2016 and 2019 from pediatric outpatient medical clinics were affiliated with a northwestern United States medical center and children’s hospital. Pediatric patients (n = 12,613) between 0–17 years old who received a PO during outpatient care were included. Patients with chronic health conditions (e.g., cancer) or who received their PO from an inpatient medical setting were excluded. Patient demographics, medication instructions, associated diagnoses, and other prescription information (e.g., name of medication, dose, and quantity dispensed) were examined using automated text classification. Many label instructions did not include any indication/reason for use (20.8%). Virtually none of the POs (>99%) included instructions for how to reduce/wean off POs, contact information for questions about the POs, and/or instructions around how to dispose of the POs. Efforts are needed to ensure that pediatric PO instructions contain essential elements to improve comprehension of when and how to use POs for pediatric patients. |
| first_indexed | 2024-03-10T03:08:47Z |
| format | Article |
| id | doaj.art-828d7948fc564f16a415d13d75241ed3 |
| institution | Directory Open Access Journal |
| issn | 2227-9067 |
| language | English |
| last_indexed | 2024-03-10T03:08:47Z |
| publishDate | 2022-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Children |
| spelling | doaj.art-828d7948fc564f16a415d13d75241ed32023-11-23T10:31:12ZengMDPI AGChildren2227-90672022-05-019570710.3390/children9050707Evaluating Providers’ Prescription Opioid Instructions to Pediatric PatientsDenise D. Tran0Patrick C. M. Brown1Corrin Murphy2Diana Ho3Karen A. Hudson4Anna C. Wilson5Sarah W. Feldstein Ewing6Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USADepartment of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USADepartment of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USADepartment of Psychology, University of Rhode Island, Kingston, RI 02881, USADepartment of Psychology, University of Rhode Island, Kingston, RI 02881, USADepartment of Pediatrics, Oregon Health & Science University, Portland, OR 97239, USADepartment of Psychology, University of Rhode Island, Kingston, RI 02881, USAReceiving an opioid prescription during childhood increases the risk of hazardous prescription opioid (PO) use during emerging adulthood. Instruction on how to safely use POs plays an essential role in pediatric patients’ capacity to utilize as well as to discontinue POs appropriately. This study aimed to evaluate pediatric PO label instructions provided to a large sample of pediatric outpatients. Data were extracted from the electronic healthcare records system identifying pediatric patients who received a PO between 2016 and 2019 from pediatric outpatient medical clinics were affiliated with a northwestern United States medical center and children’s hospital. Pediatric patients (n = 12,613) between 0–17 years old who received a PO during outpatient care were included. Patients with chronic health conditions (e.g., cancer) or who received their PO from an inpatient medical setting were excluded. Patient demographics, medication instructions, associated diagnoses, and other prescription information (e.g., name of medication, dose, and quantity dispensed) were examined using automated text classification. Many label instructions did not include any indication/reason for use (20.8%). Virtually none of the POs (>99%) included instructions for how to reduce/wean off POs, contact information for questions about the POs, and/or instructions around how to dispose of the POs. Efforts are needed to ensure that pediatric PO instructions contain essential elements to improve comprehension of when and how to use POs for pediatric patients.https://www.mdpi.com/2227-9067/9/5/707pediatricchildren/adolescentspediatric opioidsmedication instructions |
| spellingShingle | Denise D. Tran Patrick C. M. Brown Corrin Murphy Diana Ho Karen A. Hudson Anna C. Wilson Sarah W. Feldstein Ewing Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients Children pediatric children/adolescents pediatric opioids medication instructions |
| title | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
| title_full | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
| title_fullStr | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
| title_full_unstemmed | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
| title_short | Evaluating Providers’ Prescription Opioid Instructions to Pediatric Patients |
| title_sort | evaluating providers prescription opioid instructions to pediatric patients |
| topic | pediatric children/adolescents pediatric opioids medication instructions |
| url | https://www.mdpi.com/2227-9067/9/5/707 |
| work_keys_str_mv | AT denisedtran evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT patrickcmbrown evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT corrinmurphy evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT dianaho evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT karenahudson evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT annacwilson evaluatingprovidersprescriptionopioidinstructionstopediatricpatients AT sarahwfeldsteinewing evaluatingprovidersprescriptionopioidinstructionstopediatricpatients |